Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05452681

Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
Female
Age
18 Years – 44 Years
Healthy volunteers
Not accepted

Summary

The purpose of this two-arm pilot RCT is to evaluate processes and preliminary outcomes of a targeted QOL intervention vs. an attention control among young AA survivors post-treatment for early (I-II) \& late (III) stage breast cancer.

Detailed description

Primary Objectives I. Evaluate feasibility and acceptability of Y-AMBIENT and an attention control among young African American breast cancer survivors. II. Explore the degree to which the Y-AMBIENT vs. attention control affects preliminary health-related outcomes among young African American (AA) survivors. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I (Y-AMBIENT): Patients receive three themed education sessions over 1 hour each, written materials, and videos at month 1. Patients also participate in 3, 20 minutes telephone reinforcement calls to discuss how they are doing and discuss any concerns that they are still managing at months 2, 3, and 4. ARM II (ATTENTION CONTROL): Patients receive three themed education sessions over 1 hour each, written materials, and videos at month 1. Patients also participate in 3, 20 minutes telephone reinforcement calls to discuss how they are doing and discuss any concerns that they are still managing at months 2, 3, and 4. After completion of study, patients are followed up at 1 month.

Conditions

Interventions

TypeNameDescription
OTHEREducational InterventionReceive Y-AMBIENT
OTHERQuality-of-Life AssessmentAncillary studies
OTHERQuestionnaire AdministrationAncillary studies
OTHERControl InterventionReceive cookbook and socialization calls

Timeline

Start date
2022-06-01
Primary completion
2025-12-30
Completion
2025-12-31
First posted
2022-07-11
Last updated
2025-08-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05452681. Inclusion in this directory is not an endorsement.